Preclinical Study Explores Approved Drug for Ovarian Cancer (IMAGE)

Weill Cornell Medicine

Preclinical Study Explores Approved Drug for Ovarian Cancer

Caption

Treatment with the iron-binding drug deferiprone elicits a natural killer cell (brown) response in a preclinical model of ovarian cancer. Cisplatin, a chemotherapeutic agent, kills cells by a different mechanism.

Credit

Dr. Tito Sandoval

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.